Tag: KEYNOTE-146

Adding lenvatinib to pembrolizumab does not improve survival in advanced urothelial carcinoma

Presented By
Dr Yohann Loriot, Institut Gustave Roussy, France
Trial
Phase 3, LEAP-011
Conference
ASCO GU 2022
Type
Peer-reviewed article

8 April 2022 11:18
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com